c‐Myc has not been described as a transcriptional partner of NFATc2 previously, although one study has shown NFATc2 to upregulate MYC by binding its promoter [35]; while we did not find this from ChIP‐seq or NFATC2 OE experiments, the context of this study was in non‐AML cells. This evidence concerns the gene MYC and acute myeloid leukemia.